AGENUS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
AGENUS INC (AGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.32 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 4.28M shares, a 954.69% increase year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 40.90K shares, a 54.62% decline year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 30.39K shares, a 98.45% decline year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 102.87K shares, a 303.09% increase year-over-year.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 628.82K shares, a 81.14% decline from fiscal 2024.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.33M shares, a 68.95% decline from fiscal 2023.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 10.74M shares, a 33.62% increase from fiscal 2022.
- AGENUS INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 8.04M shares, a 10.74% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 4.28M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 4.32M shares 10-Q · filed 2026-08-07 | 4.35M shares derived: sum of 3 quarters · filed 2026-08-07 | 4.45M shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 40.90K shares 10-Q · filed 2026-05-11 | 71.29K shares derived: sum of 2 quarters · filed 2026-05-11 | 174.16K shares derived: sum of 3 quarters · filed 2026-05-11 | 579.59K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 30.39K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 133.25K shares derived: sum of 2 quarters · filed 2026-03-16 | 538.68K shares derived: sum of 3 quarters · filed 2026-03-16 | 628.82K shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 102.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 508.30K shares derived: sum of 2 quarters · filed 2025-11-10 | 598.43K shares 10-Q · filed 2025-11-10 | 2.56M shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 405.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 495.56K shares 10-Q · filed 2025-08-11 | 2.46M shares derived: sum of 3 quarters · filed 2025-08-11 | 2.49M shares derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | 90.13K shares 10-Q · filed 2025-05-12 | 2.05M shares derived: sum of 2 quarters · filed 2025-05-12 | 2.08M shares derived: sum of 3 quarters · filed 2025-05-12 | 3.26M shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 1.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 1.99M shares derived: sum of 2 quarters · filed 2025-03-17 | 3.17M shares derived: sum of 3 quarters · filed 2025-03-17 | 3.33M shares 10-K · filed 2025-03-17 |
| 2024-09-30 | 25.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 1.21M shares derived: sum of 2 quarters · filed 2024-11-12 | 1.37M shares 10-Q · filed 2024-11-12 | 1.67M shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 1.18M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.34M shares 10-Q · filed 2024-08-08 | 1.64M shares derived: sum of 3 quarters · filed 2024-08-08 | 2.65M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 164.51K shares 10-Q · filed 2024-05-07 | 464.02K shares derived: sum of 2 quarters · filed 2024-05-07 | 1.46M shares derived: sum of 3 quarters · filed 2024-05-07 | 2.96M shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 299.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 1.30M shares derived: sum of 2 quarters · filed 2024-03-14 | 2.80M shares derived: sum of 3 quarters · filed 2024-03-14 | 10.74M shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 1.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 2.50M shares derived: sum of 2 quarters · filed 2023-11-09 | 10.44M shares 10-Q · filed 2023-11-09 | 10.75M shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 1.50M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 9.44M shares 10-Q · filed 2023-08-08 | 9.75M shares derived: sum of 3 quarters · filed 2023-08-08 | 10.62M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 7.94M shares 10-Q · filed 2023-05-09 | 8.25M shares derived: sum of 2 quarters · filed 2023-05-09 | 9.13M shares derived: sum of 3 quarters · filed 2023-05-09 | 9.77M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 308.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 1.19M shares derived: sum of 2 quarters · filed 2023-03-16 | 1.82M shares derived: sum of 3 quarters · filed 2023-03-16 | 8.04M shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 876.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 1.52M shares derived: sum of 2 quarters · filed 2022-11-08 | 7.73M shares 10-Q · filed 2022-11-08 | 8.29M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 638.71K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 6.85M shares 10-Q · filed 2022-08-09 | 7.41M shares derived: sum of 3 quarters · filed 2022-08-09 | 7.89M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 6.21M shares 10-Q · filed 2022-05-10 | 6.77M shares derived: sum of 2 quarters · filed 2022-05-10 | 7.25M shares derived: sum of 3 quarters · filed 2022-05-10 | 12.74M shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 557.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 1.04M shares derived: sum of 2 quarters · filed 2022-03-01 | 6.53M shares derived: sum of 3 quarters · filed 2022-03-01 | 9.01M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 482.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 5.97M shares derived: sum of 2 quarters · filed 2021-11-09 | 8.45M shares 10-Q · filed 2021-11-09 | 13.27M shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 5.49M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 7.97M shares 10-Q · filed 2021-08-09 | 12.79M shares derived: sum of 3 quarters · filed 2021-08-09 | 12.96M shares derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | 2.48M shares 10-Q · filed 2021-05-07 | 7.30M shares derived: sum of 2 quarters · filed 2021-05-07 | 7.47M shares derived: sum of 3 quarters · filed 2021-05-07 | 7.72M shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-12-31 | 4.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 5.00M shares derived: sum of 2 quarters · filed 2021-03-16 | 5.25M shares derived: sum of 3 quarters · filed 2021-03-16 | 7.33M shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 174.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | 425.01K shares derived: sum of 2 quarters · filed 2020-11-09 | 2.51M shares 10-Q · filed 2020-11-09 | 6.64M shares derived: sum of 4 quarters · filed 2020-11-09 |
| 2020-06-30 | 250.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | 2.33M shares 10-Q · filed 2020-08-10 | 6.47M shares derived: sum of 3 quarters · filed 2020-08-10 | 8.16M shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 2.08M shares 10-Q · filed 2020-05-11 | 6.22M shares derived: sum of 2 quarters · filed 2020-05-11 | 7.91M shares derived: sum of 3 quarters · filed 2020-05-11 | 13.52M shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | 4.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | 5.82M shares derived: sum of 2 quarters · filed 2020-03-16 | 11.44M shares derived: sum of 3 quarters · filed 2020-03-16 | 11.58M shares 10-K · filed 2020-03-16 |
| 2019-09-30 | 1.69M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 7.30M shares derived: sum of 2 quarters · filed 2019-11-07 | 7.44M shares 10-Q · filed 2019-11-07 | 9.54M shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 5.61M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 5.76M shares 10-Q · filed 2019-08-09 | 7.85M shares derived: sum of 3 quarters · filed 2019-08-09 | 8.16M shares derived: sum of 4 quarters · filed 2019-08-09 |
| 2019-03-31 | 143.00K shares 10-Q · filed 2019-05-10 | 2.24M shares derived: sum of 2 quarters · filed 2019-05-10 | 2.54M shares derived: sum of 3 quarters · filed 2019-05-10 | 5.95M shares derived: sum of 4 quarters · filed 2019-05-10 |
| 2018-12-31 | 2.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 2.40M shares derived: sum of 2 quarters · filed 2019-03-18 | 5.81M shares derived: sum of 3 quarters · filed 2019-03-18 | 6.20M shares 10-K · filed 2019-03-18 |
| 2018-09-30 | 305.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | 3.71M shares derived: sum of 2 quarters · filed 2018-11-07 | 4.10M shares 10-Q · filed 2018-11-07 | 4.35M shares derived: sum of 4 quarters · filed 2018-11-07 |
| 2018-06-30 | 3.41M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 3.80M shares 10-Q · filed 2018-08-09 | 4.05M shares derived: sum of 3 quarters · filed 2018-08-09 | 4.27M shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 387.73K shares 10-Q · filed 2018-05-10 | 637.82K shares derived: sum of 2 quarters · filed 2018-05-10 | 866.57K shares derived: sum of 3 quarters · filed 2018-05-10 | 1.38M shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 250.09K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 478.83K shares derived: sum of 2 quarters · filed 2018-03-16 | 994.66K shares derived: sum of 3 quarters · filed 2018-03-16 | 4.50M shares 10-K · filed 2018-03-16 |
| 2017-09-30 | 228.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 744.58K shares derived: sum of 2 quarters · filed 2017-11-07 | 4.25M shares 10-Q · filed 2017-11-07 | 4.57M shares derived: sum of 4 quarters · filed 2017-11-07 |
| 2017-06-30 | 515.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | 4.02M shares 10-Q · filed 2017-08-07 | 4.34M shares derived: sum of 3 quarters · filed 2017-08-07 | 4.93M shares derived: sum of 4 quarters · filed 2017-08-07 |
| 2017-03-31 | 3.50M shares 10-Q · filed 2017-05-04 | 3.82M shares derived: sum of 2 quarters · filed 2017-05-04 | 4.41M shares derived: sum of 3 quarters · filed 2017-05-04 | |
| 2016-12-31 | 319.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 909.23K shares derived: sum of 2 quarters · filed 2017-03-16 | 4.57M shares 10-K · filed 2017-03-16 | |
| 2016-09-30 | 589.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 4.25M shares 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | 3.66M shares 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |